DTE

30.42

-3.86%↓

IBE

15.685

-0.03%↓

ENGI

17.78

+0.94%↑

ORA

13.535

-0.33%↓

EOAN

15.31

+1.29%↑

DTE

30.42

-3.86%↓

IBE

15.685

-0.03%↓

ENGI

17.78

+0.94%↑

ORA

13.535

-0.33%↓

EOAN

15.31

+1.29%↑

DTE

30.42

-3.86%↓

IBE

15.685

-0.03%↓

ENGI

17.78

+0.94%↑

ORA

13.535

-0.33%↓

EOAN

15.31

+1.29%↑

DTE

30.42

-3.86%↓

IBE

15.685

-0.03%↓

ENGI

17.78

+0.94%↑

ORA

13.535

-0.33%↓

EOAN

15.31

+1.29%↑

DTE

30.42

-3.86%↓

IBE

15.685

-0.03%↓

ENGI

17.78

+0.94%↑

ORA

13.535

-0.33%↓

EOAN

15.31

+1.29%↑

Strona główna・Stock List・STRATEC Biomedical AG

STRATEC Biomedical AG

Closed

26.25 1.16

Buy Sell

Overview

Share price change

24h

Current

Min

25.8

Max

26.35

Key metrics
By Trading Economics
Income	11M 12M
Sales	24M 81M
P/E Sector Avg	22 24.213
EPS	0.09
Dividend yield	2.21
Profit margin	14.203
Employees	1,416
EBITDA	16M 23M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+41.22% upside

Dividends
By Dow Jones
Dividend yield Sector Avg	2.21% 3.75%
Next Earnings	7 lis 2025

Market Stats
By TradingEconomics
Market Cap	6.7M 321M
Previous open	25.09
Previous close	26.25

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

N/A / 24.5 Support & Resistance

STRATEC Biomedical AG Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 lip 2025, 17:24 UTC

Market Talk

Election, Dollar Seen as Potential Headwinds for Ibovespa -- Market Talk

Peer Comparison

Price change

STRATEC Biomedical AG Forecast

Price Target

By TipRanks

41.22% upside

12 Months Forecast

Average 37 EUR 41.22%

High 51 EUR

Low 30 EUR

Based on 4 Wall Street analysts offering 12 month price targets forSTRATEC Biomedical AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

4 ratings

Buy

Hold

Sell

Based on 4 analysts giving stock ratings to STRATEC Biomedical AG - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 24.5Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

There are no events.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About STRATEC Biomedical AG

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.